All filters
E-Posters
High Seroprevalence Of Viral Hepatitis Among Animal Handlers In Abeokuta, Nigeria
A. Oluremi
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Validation Of A Novel Point-Of-Care Alt Test To Determine Treatment Eligibility In Hepatitis B Patients: A Pilot Cohort Study
J. Howell
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Seroprevalence Of Hepatitis B Surface Antigen (HBsAg) And Hepatitis C Antibodies (HCAb) Among Hemodialysis Patients At The Yaounde General Hospital, Cameroon
K. W. Rodrigue
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Expression Of HBeAg, HBsAg, Anti- HBe And Anti-HCV In Individuals With Elevated Il-10
M. F. Olaniyan
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Seroprevalence Of Viral Hepatitis Among Health Care Workers (HCWs) In Taraba State, Nigeria
O. Tiwah John
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Results From Two Phase-3 Double-Blind, Randomized, Controlled Trials, Protect And Constant, Evaluating Immunogenicity And Safety Of The 3-Antigen Hepatitis B Vaccine, Sci-B-Vac®, Compared To The Single-Antigen Vaccine, Engerix ® In Adults
F. Diaz-Mitoma
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Evaluation Of Hepatitis B Vaccine Efficacy Among Healthcare Worker At Laquintinie Hospital, Douala, Cameroon
K. W. Rodrigue
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Hep Free 2030: Planning For Hepatitis Elimination In Hawaii As Nimble, Collaborative Practice
T. Pham
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Ledipasvir 90 Mg/ Sofosbuvir 400 Mg For Treatment Of Chronic Hepatitis C Genotype 4 Adolescents: Towards Elimination Of Hepatitis In Children
R. Soliman
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Results Of A Hepatitis C (HCV) Re-Engagement Strategy For Vulnerable Populations
G. Macphail
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Gilead Sciences’ Commitment To Global Elimination Of Hepatitis C Virus
A. Son
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Contact Tracing To Engage Hard To Reach Injection Networks And Achieve Micro-Elimination: Description Of The ‘Source Patient Indentification And Group Overlap Treatment’ (Spigot) Pilot Program
B. Eckhardt
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Global Elimination Of Hepatitis C: Meeting The World Health Organization’S 2030 Goal
E. Abernathy
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
E-Posters
Breaking Bad: Chems, Sex And Sexual Health
M. Reiriz Rojas
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Determination Of Drug Resistance Of Hepatitis C Virus To NS5A Protein Inhibitors As A New Approach To Personalized Medicine
E. Gasich
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Using Next-Generation Sequencing To Assess The Differences In HIV Drug Resistance Pre- And Post-Treatment In A Treatment As Prevention Trial
S. Kemp
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Association Of Viral Reservoir With HIV Infection Duration, Viral Load And CD4 Count
D. Kireev
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Creation Of An Italian HIV Dna Network For The Validation And Clinical Use Of HIV-1 DNA Quantification Assays
I. Vicenti
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Exploratory Evaluation For The Optimization Of Next Generation Sequencing HIV-1 Drug Resistance Outcomes Based On An In-House RNA Extraction Protocol
A. Orta-Resendiz
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Associations Between Vitamin D And Fibrosis, Genotype, Viral Load In Patients Having Chronic Hepatitis C
M. Nikolaichuk
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
The Quantification Of HBeAg Levels Differ Among The Different Phases Of Hbv Infection, And Can Predict Therapeutic Outcome In The Setting Of Immunosuppression Driven Hbv Reactivation
L. Piermatteo
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Combined Use Of High-Sensitivity Serological And Virological Hbv Markers Can Make Better In Predicting The Occurrence Of HBV Reactivation And To Optimize Prophylaxis Duration In HBsAg-Negative/Anti-HBc-Positive Patients In The Context Of Oncohematological
M. Alkhatib
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
The Effectiveness Of The Application Of Serological Tests And Laboratory Indicators As Part Of Rita For The Detection Of Recent HIV Infection
A. Murzakova
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Ibalizumab Shows In Vitro Activity Against Group A And Group B HIV-2 Clinical Isolates
C. Charpentier
Presented at:
European Meeting on HIV & Hepatitis 2020